New nano approach could cut dose of leading HIV treatment in half
Successful results of a University of Liverpool-led trial that utilised nanotechnology to improve drug therapies for HIV patients has been presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, a leading annual conference of HIV research, clinical practice and progress. The healthy volunteer trial, conducted by the collaborative nanomedicine research programme led […]
